THU195 6-Month Subcutaneous Leuprolide Acetate Achieved And Maintained Hormonal And Clinical Suppression In All Weight Groups Of Children With Central Precocious Puberty

Disclosure: B.S. Miller: Consulting Fee; Self; Abbvie, Ascendis Pharma, Bristol Myers Squibb, BioMarin, Endo Pharmaceuticals, EMD Serono, Novo Nordisk, Pfizer, Tolmar Pharmaceuticals. Research Investigator; Self; Alexion, Abbvie, Aeterna Zentaris, Amicus, Lumos Pharma, Lysogene, Novo Nordisk, OPKO H...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Bradley S, Boldt-Houle, Deborah, Atkinson, Stuart N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554133/
http://dx.doi.org/10.1210/jendso/bvad114.1446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554133/
http://dx.doi.org/10.1210/jendso/bvad114.1446

Ejemplares similares